Companies:
49,720
Total Market Cap:
134361334404297.48
Global Rank
#32267
Country Rank
#2001
Market Cap
34.25 M
Price
2.19
Change (%)
0.17%
Volume
14,536
Biotoxtech's latest marketcap:
34.25 M
As of 06/24/2025, Biotoxtech's market capitalization has reached $34.25 M. According to our data, Biotoxtech is the 32267th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 34.25 M |
| Revenue (ttm) | 31.87 M |
| Net Income (ttm) | -4,833,539.08 |
| Shares Out | 15.72 M |
| EPS (ttm) | -0.34 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Market Cap Chart
Data Updated: 06/24/2025
Biotoxtech's yearly market capitalization.
Biotoxtech has seen its market value drop from ₩44.33 B to ₩34.25 M since 2014, representing a total decrease of 99.92% and an annual compound decline rate (CAGR) of 49.51%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/24/2025 | ₩34.25 M | -10.19% | 32267 |
| 12/30/2024 | ₩52.43 B | -46.56% | 30409 |
| 12/28/2023 | ₩98.11 B | -17.65% | 24958 |
| 12/29/2022 | ₩119.14 B | 1.5% | 22677 |
| 12/30/2021 | ₩117.38 B | -47.08% | 23191 |
| 12/30/2020 | ₩221.83 B | 142.66% | 16665 |
| 12/30/2019 | ₩91.42 B | -24.31% | 19388 |
| 12/28/2018 | ₩120.78 B | 18.85% | 16912 |
| 12/28/2017 | ₩101.62 B | 24.99% | 18282 |
| 12/29/2016 | ₩81.3 B | 3.87% | 17922 |
Company Profile
About Biotoxtech Co., Ltd.
Biotoxtech Co., Ltd. is a South Korean company specializing in the safety evaluation of various products, including:
- Synthetic medicines
- Biomedicines
- Cell therapy products
- Gene therapy products
- Health functional foods
- Chemicals
- Pesticides
Core Services
The company provides comprehensive services in:
- Testing and substance screening
- Clinical pathology and histopathology
- Consulting and government affairs for non-clinical trials
- New drug development support
Safety Evaluation Research
Biotoxtech's expertise includes:
- General toxicity testing
- Carcinogenicity studies
- Local toxicity studies
- Reproductive and developmental studies
- Genotoxicity testing
- Immunotoxicity testing
- Safety pharmacology testing
- Aquatic ecotoxicology testing
- Histopathology/clinical pathology
- Animal testing methodologies
Founded: 2000
Headquarters: Cheongwon, South Korea
Frequently Asked Questions
-
What is Biotoxtech's (KOSDAQ-086040) current market cap?As of 06/24/2025, Biotoxtech (including the parent company, if applicable) has an estimated market capitalization of $34.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Biotoxtech (KOSDAQ-086040) rank globally by market cap?Biotoxtech global market capitalization ranking is approximately 32267 as of 06/24/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.